Marimed Inc.

06/08/2026 | Press release | Distributed by Public on 06/08/2026 14:18

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to Vote of Security Holders.
On June 4, 2026, MariMed Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting") to consider and vote on the matters listed below. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 23, 2026. At the Annual Meeting, the Company's stockholders:
•re-elected four directors of the Company to serve until the Company's next annual meeting of stockholders or until their respective successors have been duly elected and qualified ("Election of Directors"); and
•approved, on an advisory basis, the appointment of M&K CPAs PLLC as the Company's independent auditors for the 2026 fiscal year the ("Advisory Approval of Auditors").
The specific votes were as follows:
1. Election of Directors:
VOTES
NAME FOR WITHHELD BROKER NON-VOTE
Jon R. Levine 111,339,122 14,355,396 119,765,107
Edward Gildea 110,868,950 14,825,568 119,765,107
David Allen 110,854,282 14,840,236 119,765,107
Eva Selhub, M.D. 111,358,888 14,335,630 119,765,107
2. Advisory Approval of Auditors:
VOTES
FOR AGAINST ABSTAIN/WITHHELD
229,335,138 15,550,371 574,116
Marimed Inc. published this content on June 08, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 08, 2026 at 20:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]